메뉴 건너뛰기




Volumn 6, Issue 1, 2016, Pages

Renal PET-imaging with 11C-metformin in a transgenic mouse model for chronic kidney disease

Author keywords

11C metformin; Chronic kidney disease; Mouse model; PET

Indexed keywords

CARBON 11; MESSENGER RNA; METFORMIN; MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2;

EID: 84976277176     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/s13550-016-0211-x     Document Type: Article
Times cited : (5)

References (24)
  • 1
    • 35848968871 scopus 로고    scopus 로고
    • Prevalence of chronic kidney disease in the United States
    • COI: 1:CAS:528:DC%2BD2sXht1yjsLnM, PID: 17986697
    • Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van LF, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47. doi:10.1001/jama.298.17.2038.
    • (2007) JAMA , vol.298 , pp. 2038-2047
    • Coresh, J.1    Selvin, E.2    Stevens, L.A.3    Manzi, J.4    Kusek, J.W.5    Eggers, P.6    Van, L.F.7    Levey, A.S.8
  • 5
    • 84857443066 scopus 로고    scopus 로고
    • Epidemiology and prognostic significance of chronic kidney disease in the elderly—the Three-City prospective cohort study
    • PID: 21677301
    • Stengel B, Metzger M, Froissart M, Rainfray M, Berr C, Tzourio C, Helmer C. Epidemiology and prognostic significance of chronic kidney disease in the elderly—the Three-City prospective cohort study. Nephrol Dial Transplant. 2011;26:3286–95. doi:10.1093/ndt/gfr323.
    • (2011) Nephrol Dial Transplant , vol.26 , pp. 3286-3295
    • Stengel, B.1    Metzger, M.2    Froissart, M.3    Rainfray, M.4    Berr, C.5    Tzourio, C.6    Helmer, C.7
  • 7
    • 0035991421 scopus 로고    scopus 로고
    • Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy
    • COI: 1:CAS:528:DC%2BD38Xmt1Gls7o%3D, PID: 12110012
    • Ji L, Masuda S, Saito H, Inui K. Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. Kidney Int. 2002;62:514–24. doi:10.1046/j.1523-1755.2002.00464.x.
    • (2002) Kidney Int , vol.62 , pp. 514-524
    • Ji, L.1    Masuda, S.2    Saito, H.3    Inui, K.4
  • 8
    • 59849111486 scopus 로고    scopus 로고
    • Testosterone-independent down-regulation of Oct2 in the kidney medulla from a uranyl nitrate-induced rat model of acute renal failure: effects on distribution of a model organic cation, tetraethylammonium
    • COI: 1:CAS:528:DC%2BD1MXhs1KmtLg%3D, PID: 18484100
    • Shim WS, Park JH, Ahn SJ, Han L, Jin QR, Li H, Choi MK, Kim DD, Chung SJ, Shim CK. Testosterone-independent down-regulation of Oct2 in the kidney medulla from a uranyl nitrate-induced rat model of acute renal failure: effects on distribution of a model organic cation, tetraethylammonium. J Pharm Sci. 2009;98:739–47. doi:10.1002/jps.21442.
    • (2009) J Pharm Sci , vol.98 , pp. 739-747
    • Shim, W.S.1    Park, J.H.2    Ahn, S.J.3    Han, L.4    Jin, Q.R.5    Li, H.6    Choi, M.K.7    Kim, D.D.8    Chung, S.J.9    Shim, C.K.10
  • 9
    • 34249943356 scopus 로고    scopus 로고
    • Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications
    • COI: 1:CAS:528:DC%2BD2sXnt1Clu7Y%3D, PID: 17473959
    • Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res. 2007;24:1227–51. doi:10.1007/s11095-007-9254-z.
    • (2007) Pharm Res , vol.24 , pp. 1227-1251
    • Koepsell, H.1    Lips, K.2    Volk, C.3
  • 10
    • 0032456205 scopus 로고    scopus 로고
    • Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs
    • COI: 1:CAS:528:DyaK1cXnsVerurk%3D, PID: 9808712
    • Urakami Y, Okuda M, Masuda S, Saito H, Inui KI. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. J Pharmacol Exp Ther. 1998;287:800–5.
    • (1998) J Pharmacol Exp Ther , vol.287 , pp. 800-805
    • Urakami, Y.1    Okuda, M.2    Masuda, S.3    Saito, H.4    Inui, K.I.5
  • 11
    • 84963956559 scopus 로고    scopus 로고
    • A PET tracer for renal organic cation transporters, 11c-metformin: radiosynthesis and preclinical proof-of-concept studies
    • Jakobsen S, Busk M, Jensen JB, Munk OL, Zois NE, Alstrup AK, Jessen N, Frokiaer J. A PET tracer for renal organic cation transporters, 11c-metformin: radiosynthesis and preclinical proof-of-concept studies. J Nucl Med. 2016. doi:10.2967/jnumed.115.169292.
    • (2016) J Nucl Med
    • Jakobsen, S.1    Busk, M.2    Jensen, J.B.3    Munk, O.L.4    Zois, N.E.5    Alstrup, A.K.6    Jessen, N.7    Frokiaer, J.8
  • 12
    • 84862066298 scopus 로고    scopus 로고
    • Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics
    • COI: 1:CAS:528:DC%2BC38XotlWns70%3D, PID: 22407892
    • Higgins JW, Bedwell DW, Zamek-Gliszczynski MJ. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics. Drug Metab Dispos. 2012;40:1170–7. doi:10.1124/dmd.112.044875.
    • (2012) Drug Metab Dispos , vol.40 , pp. 1170-1177
    • Higgins, J.W.1    Bedwell, D.W.2    Zamek-Gliszczynski, M.J.3
  • 13
    • 66849142125 scopus 로고    scopus 로고
    • Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin
    • COI: 1:CAS:528:DC%2BD1MXmvVWqsLo%3D, PID: 19332510
    • Tsuda M, Terada T, Mizuno T, Katsura T, Shimakura J, Inui K. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin. Mol Pharmacol. 2009;75:1280–6. doi:10.1124/mol.109.056242.
    • (2009) Mol Pharmacol , vol.75 , pp. 1280-1286
    • Tsuda, M.1    Terada, T.2    Mizuno, T.3    Katsura, T.4    Shimakura, J.5    Inui, K.6
  • 15
    • 0034353181 scopus 로고    scopus 로고
    • TGF-b1-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man
    • COI: 1:CAS:528:DC%2BD3MXktFSgtg%3D%3D, PID: 11140698
    • Krag S, Østerby R, Chai Q, Nielsen B, Hermans C, Wogensen L. TGF-b1-induced glomerular disorder is associated with impaired concentrating ability mimicking primary glomerular disease with renal failure in man. Lab Invest. 2000;80:1855–68.
    • (2000) Lab Invest , vol.80 , pp. 1855-1868
    • Krag, S.1    Østerby, R.2    Chai, Q.3    Nielsen, B.4    Hermans, C.5    Wogensen, L.6
  • 16
    • 0032589897 scopus 로고    scopus 로고
    • Under control of the Renin-1c promoter, locally, produced transforming growth factor-b1 induces accumulation of glomerular extracellular matrix in transgenic mice
    • COI: 1:CAS:528:DyaK1MXhvFSisA%3D%3D, PID: 9892241
    • Wogensen L, Nielsen CB, Hjorth P, Rasmussen LM, Høj Nielsen A, Gross K, Sarvetnick N, Ledet T. Under control of the Renin-1c promoter, locally, produced transforming growth factor-b1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes. 1999;48:182–92.
    • (1999) Diabetes , vol.48 , pp. 182-192
    • Wogensen, L.1    Nielsen, C.B.2    Hjorth, P.3    Rasmussen, L.M.4    Høj Nielsen, A.5    Gross, K.6    Sarvetnick, N.7    Ledet, T.8
  • 17
    • 84969800847 scopus 로고    scopus 로고
    • [11C]-metformin distribution in the liver and small intestine using dynamic PET in mice demonstrates tissue-specific transporter dependency
    • Jensen JB, Sundelin EI, Jakobsen S, Gormsen LC, Munk OL, Frokiaer J, Jessen N. [11C]-metformin distribution in the liver and small intestine using dynamic PET in mice demonstrates tissue-specific transporter dependency. Diabetes. 2016. doi:10.2337/db16-0032.
    • (2016) Diabetes
    • Jensen, J.B.1    Sundelin, E.I.2    Jakobsen, S.3    Gormsen, L.C.4    Munk, O.L.5    Frokiaer, J.6    Jessen, N.7
  • 18
    • 84934953658 scopus 로고    scopus 로고
    • Restoration of haemoglobin level using hydrodynamic gene therapy with erythropoietin does not alleviate the disease progression in an anaemic mouse model for TGFbeta1-induced chronic kidney disease
    • PID: 26046536
    • Pedersen L, Wogensen L, Marcussen N, Cecchi CR, Dalsgaard T, Dagnaes-Hansen F. Restoration of haemoglobin level using hydrodynamic gene therapy with erythropoietin does not alleviate the disease progression in an anaemic mouse model for TGFbeta1-induced chronic kidney disease. PLoS One. 2015;10:e0128367. doi:10.1371/journal.pone.0128367.
    • (2015) PLoS One , vol.10 , pp. e0128367
    • Pedersen, L.1    Wogensen, L.2    Marcussen, N.3    Cecchi, C.R.4    Dalsgaard, T.5    Dagnaes-Hansen, F.6
  • 19
    • 0142123151 scopus 로고    scopus 로고
    • Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations
    • COI: 1:CAS:528:DC%2BD3sXosFOgtLg%3D, PID: 14560032
    • Jonker JW, Wagenaar E, Van ES, Schinkel AH. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Mol Cell Biol. 2003;23:7902–8.
    • (2003) Mol Cell Biol , vol.23 , pp. 7902-7908
    • Jonker, J.W.1    Wagenaar, E.2    Van, E.S.3    Schinkel, A.H.4
  • 21
    • 33644664085 scopus 로고    scopus 로고
    • Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1
    • COI: 1:CAS:528:DC%2BD2MXhtleksbzM, PID: 16272756
    • Kimura N, Masuda S, Tanihara Y, Ueo H, Okuda M, Katsura T, Inui K. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. Drug Metab Pharmacokinet. 2005;20:379–86.
    • (2005) Drug Metab Pharmacokinet , vol.20 , pp. 379-386
    • Kimura, N.1    Masuda, S.2    Tanihara, Y.3    Ueo, H.4    Okuda, M.5    Katsura, T.6    Inui, K.7
  • 22
    • 0028063302 scopus 로고
    • Drug excretion mediated by a new prototype of polyspecific transporter
    • COI: 1:STN:280:DyaK2M%2Fot12jtQ%3D%3D, PID: 7990927
    • Grundemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature. 1994;372:549–52. doi:10.1038/372549a0.
    • (1994) Nature , vol.372 , pp. 549-552
    • Grundemann, D.1    Gorboulev, V.2    Gambaryan, S.3    Veyhl, M.4    Koepsell, H.5
  • 23
    • 84938208500 scopus 로고    scopus 로고
    • Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study
    • COI: 1:CAS:528:DC%2BC2MXhvVSksrfM, PID: 26094107
    • Hung SC, Chang YK, Liu JS, Kuo KL, Chen YH, Hsu CC, Tarng DC. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study. Lancet Diabetes Endocrinol. 2015;3:605–14. doi:10.1016/S2213-8587(15)00123-0.
    • (2015) Lancet Diabetes Endocrinol , vol.3 , pp. 605-614
    • Hung, S.C.1    Chang, Y.K.2    Liu, J.S.3    Kuo, K.L.4    Chen, Y.H.5    Hsu, C.C.6    Tarng, D.C.7
  • 24
    • 84889038435 scopus 로고    scopus 로고
    • Unleash metformin: reconsideration of the contraindication in patients with renal impairment
    • PID: 24259604
    • Lu WR, Defilippi J, Braun A. Unleash metformin: reconsideration of the contraindication in patients with renal impairment. Ann Pharmacother. 2013;47:1488–97. doi:10.1177/1060028013505428.
    • (2013) Ann Pharmacother , vol.47 , pp. 1488-1497
    • Lu, W.R.1    Defilippi, J.2    Braun, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.